Adalta Capital Management LLC Gilead Sciences, Inc. Transaction History

Adalta Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 17, 2021	SELL	$56.65 - $64.55 $169,950 - $193,650	-3,000 Closed	0 $0
Q1 2020 May 18, 2020	BUY	$62.63 - $80.22 $187,890 - $240,660	3,000 New	3,000 $224,000
Q3 2019 Nov 15, 2019	SELL	$62.51 - $69.0 $187,530 - $207,000	-3,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $185,610 - $208,140	3,000 New	3,000 $203,000
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $181,620 - $237,000	-3,000 Closed	0 $0
Q3 2017 Nov 24, 2017	BUY	$72.11 - $85.47 $216,330 - $256,410	3,000	3,000 $243,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Adalta Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Adalta Capital Management LLC with notifications on news.